GL1X · GenesisL1 explorer

MolNFT v1 · #179309 · protein

Crystal structure of NSP15 endoribonuclease from SARS cov-2 in the complex with uridine-2',3'-vanadate

7K1L · Uridylate-specific endoribonuclease: “Crystal structure of NSP15 endoribonuclease from SARS cov-2 in the complex with uridine-2',3'-vanadate”. X-ray diffraction, 2 ligands (UVC, SO4), 5 pockets (best druggability 0.58). MolNFT v1…

PDB
7K1L
Type
protein
Length
694 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Uridylate-specific endoribonuclease
EC
3.1.-.-
UniProt
P0DTD1
Ligands
UVC, SO4
Pockets
5 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 22% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BUridylate-specific endoribonuclease (EC 3.1.-.-)protein34722% helix, 31% strandP0DTD1

Ligands and binding sites

  • UVC · Uridine-2',3'-vanadate · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B
  • ACT · Acetate ion · additive · 2 copies · chains A
  • EDO · 1,2-ethanediol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12060.580.8027empty
21800.540.7927empty
32890.510.7432empty
4790.320.7416EDO
5550.250.7313empty

Interfaces

1 interface between chains.

  • A–B · 75 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 7K1L · Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.